Question 1

What are Chronic Pain?

Accepted Answer

The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. It may be due to an injury or the brain’s inability to process pain signals properly. Chronic pain can range from mild to severe and is present for long periods (>3 months) and is often the result of a disease that may require ongoing treatment. The most common sources of chronic pain include low back pain, musculoskeletal pain, migraines, fibromyalgia, neuralgia, cancer pain, visceral, and postoperative pain. With many chronic conditions, the cause of the pain is unknown.

Question 2

How is Chronic Pain epidemiology segmented?

Accepted Answer

Chronic Pain epidemiology is segmented as Chronic Pain Total Incident Cases, Age-specific Chronic Pain cases, Gender-specific Chronic Pain Cases, Stage-specific Chronic Pain incident cases, Type-specific Chronic Pain incident cases, and Total Treated Chronic Pain Cases.

Question 3

What is the Chronic Pain market size in 7MM?

Accepted Answer

The Chronic Pain market size was found to be USD 20 billion in 2021.

Question 4

At what CAGR is the Chronic Pain Market expected to grow by 2032?

Accepted Answer

The Chronic Pain Market is expected to grow at a moderate CAGR during the study period 2019–2032.

Question 5

Which country is expected to account for the most significant Chronic Pain prevalent cases in the 7MM?

Accepted Answer

The United States is expected to account for the highest prevalent Chronic Pain prevalent cases.

Question 6

What are the key Chronic Pain companies?

Accepted Answer

Some of the key Chronic Pain companies working in the Chronic Pain market are AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Pfizer, Anika Therapeutics, Biogen, Tonix Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical GmbH, and others.